drug

Cognitive Enhancement Therapy (CET)

Cognitive enhancement therapy (CET)
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Beth Israel Deaconess Medical Center
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

2
Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
NCT05365347—Recruiting
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
NCT00167362Phase 3Completed

KOLs & investigators

3
Philip G Tibbo, MDKOL score 10
Matcheri S. Keshavan, MDKOL score 9
Gerard E Hogarty, MSW

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Beth Israel Deaconess Medical Center
company
trial
Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
NA
trial
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
PHASE3
trial
indication
Schizophrenia
indication
Psychosis
indication
Alcohol Use Disorder
indication
Alcoholism
indication
KOL
Philip G Tibbo, MD
KOL score 10
person
Matcheri S. Keshavan, MD
KOL score 9
person
Gerard E Hogarty, MSW
KOL score —
person